Clinical Trial

Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 5, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to compare the live birth rates of high concentration of Hyaluronic Acid (0.5 mg/ml) transfer medium (EmbryoGlue®) to those containing low Hyaluronic Acid concentrations (0.125 mg/ml) (G2 medium) in women undergoing single fresh and frozen blastocyst transfer.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-07-01; most recent amendment 2025-11-28.
Status change: Active, Not Recruiting → Recruiting 2025-09-16
Status change: Recruiting → Active, Not Recruiting 2025-09-08
Status change: Not Yet Recruiting → Recruiting 2025-02-20
Trial Details
NCT Number NCT06492785
Lead Sponsor Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Collaborators: Jiangxi Maternal and Child Health Hospital, Gansu Provincial Maternal and Child Health Care Hospital, Huazhong University of Science and Technology
Conditions Infertility
Enrollment 858 participants
Start Date 2024-09-13
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-05